科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/19 | 5,030 | 5,140 | 5,030 | 5,130 | +130 | +2.6% | 120,600 |
2021/08/18 | 4,975 | 5,040 | 4,975 | 5,000 | +5 | +0.1% | 104,200 |
2021/08/17 | 4,965 | 5,020 | 4,965 | 4,995 | ±0 | ±0% | 61,800 |
2021/08/16 | 5,020 | 5,030 | 4,960 | 4,995 | -25 | -0.5% | 68,200 |
2021/08/13 | 4,975 | 5,040 | 4,970 | 5,020 | +80 | +1.6% | 103,700 |
2021/08/12 | 4,960 | 4,980 | 4,925 | 4,940 | -10 | -0.2% | 68,300 |
2021/08/11 | 4,925 | 4,960 | 4,905 | 4,950 | +15 | +0.3% | 77,900 |
2021/08/10 | 4,880 | 4,950 | 4,875 | 4,935 | +50 | +1% | 72,900 |
2021/08/06 | 4,870 | 4,900 | 4,850 | 4,885 | +15 | +0.3% | 54,600 |
2021/08/05 | 4,850 | 4,935 | 4,850 | 4,870 | -15 | -0.3% | 72,400 |
2021/08/04 | 4,885 | 4,950 | 4,870 | 4,885 | ±0 | ±0% | 99,000 |
2021/08/03 | 4,925 | 4,955 | 4,845 | 4,885 | -85 | -1.7% | 134,400 |
2021/08/02 | 4,900 | 4,970 | 4,895 | 4,970 | +135 | +2.8% | 118,300 |
2021/07/30 | 4,850 | 4,870 | 4,825 | 4,835 | +10 | +0.2% | 222,700 |
2021/07/29 | 4,880 | 4,895 | 4,815 | 4,825 | -80 | -1.6% | 78,700 |
2021/07/28 | 4,865 | 4,920 | 4,855 | 4,905 | -10 | -0.2% | 70,500 |
2021/07/27 | 4,930 | 4,935 | 4,895 | 4,915 | +20 | +0.4% | 83,400 |
2021/07/26 | 4,930 | 4,940 | 4,855 | 4,895 | +45 | +0.9% | 89,100 |
2021/07/21 | 4,845 | 4,875 | 4,815 | 4,850 | +15 | +0.3% | 92,100 |
2021/07/20 | 4,780 | 4,860 | 4,775 | 4,835 | +10 | +0.2% | 89,700 |
2021/07/19 | 4,785 | 4,845 | 4,780 | 4,825 | +10 | +0.2% | 85,100 |
2021/07/16 | 4,805 | 4,880 | 4,805 | 4,815 | -45 | -0.9% | 81,000 |
2021/07/15 | 4,895 | 4,960 | 4,840 | 4,860 | -10 | -0.2% | 118,900 |
2021/07/14 | 4,795 | 4,895 | 4,795 | 4,870 | +70 | +1.5% | 93,900 |
2021/07/13 | 4,815 | 4,830 | 4,800 | 4,800 | +5 | +0.1% | 76,400 |
2021/07/12 | 4,790 | 4,815 | 4,765 | 4,795 | +100 | +2.1% | 99,500 |
2021/07/09 | 4,640 | 4,715 | 4,630 | 4,695 | -15 | -0.3% | 125,500 |
2021/07/08 | 4,775 | 4,775 | 4,710 | 4,710 | -85 | -1.8% | 107,800 |
2021/07/07 | 4,760 | 4,795 | 4,725 | 4,795 | -25 | -0.5% | 104,500 |
2021/07/06 | 4,825 | 4,835 | 4,805 | 4,820 | +5 | +0.1% | 62,000 |
2021/07/05 | 4,860 | 4,895 | 4,815 | 4,815 | -45 | -0.9% | 96,000 |
2021/07/02 | 4,885 | 5,010 | 4,860 | 4,860 | +75 | +1.6% | 317,600 |
2021/07/01 | 4,760 | 4,815 | 4,750 | 4,785 | +25 | +0.5% | 97,900 |
2021/06/30 | 4,790 | 4,795 | 4,755 | 4,760 | -30 | -0.6% | 89,400 |
2021/06/29 | 4,790 | 4,815 | 4,765 | 4,790 | -45 | -0.9% | 79,800 |
2021/06/28 | 4,850 | 4,870 | 4,810 | 4,835 | +10 | +0.2% | 104,100 |
2021/06/25 | 4,840 | 4,850 | 4,790 | 4,825 | -5 | -0.1% | 91,800 |
2021/06/24 | 4,765 | 4,840 | 4,760 | 4,830 | +65 | +1.4% | 120,400 |
2021/06/23 | 4,755 | 4,810 | 4,755 | 4,765 | +5 | +0.1% | 115,700 |
2021/06/22 | 4,735 | 4,760 | 4,680 | 4,760 | +140 | +3% | 143,500 |
2021/06/21 | 4,650 | 4,665 | 4,605 | 4,620 | -120 | -2.5% | 129,700 |
2021/06/18 | 4,795 | 4,795 | 4,730 | 4,740 | -55 | -1.1% | 142,500 |
2021/06/17 | 4,770 | 4,810 | 4,765 | 4,795 | +40 | +0.8% | 108,500 |
2021/06/16 | 4,700 | 4,790 | 4,700 | 4,755 | ±0 | ±0% | 132,600 |
2021/06/15 | 4,820 | 4,835 | 4,755 | 4,755 | -65 | -1.3% | 114,800 |
2021/06/14 | 4,820 | 4,845 | 4,785 | 4,820 | +5 | +0.1% | 110,800 |
2021/06/11 | 4,795 | 4,815 | 4,765 | 4,815 | +50 | +1% | 139,200 |
2021/06/10 | 4,795 | 4,800 | 4,730 | 4,765 | +40 | +0.8% | 124,200 |
2021/06/09 | 4,710 | 4,795 | 4,710 | 4,725 | -10 | -0.2% | 120,700 |
2021/06/08 | 4,710 | 4,750 | 4,710 | 4,735 | +40 | +0.9% | 96,800 |
801~
850
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
サワイGHD | 197,200円 | +4.0% | +25.4% | 2.69% | 9.11倍 | 1.20倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
住友ファーマ | 60,900円 | +7.5% | - | 0.00% | - | 2.12倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム